Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Congenital Heart Disease: full-pipeline trial registry
33 of 64 indexed Congenital Heart Disease trials are currently recruiting.
Corpus placement: #215 of 28,707 conditions by registered trial count.
64 US clinical trials · 33 currently recruiting · #215 of 28,707 conditions by registered trial count
Congenital Heart Disease: 64 US clinical trials tracked, 33 recruiting.
Congenital Heart Disease is the subject of 64 registered US clinical trials on ClinicalTrials.gov, 33 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Boston Children's Hospital, running 9 of these trials.
Enrollment posture brief
Registry condition congenital-heart-disease
OPEN 33 | RECR 52% | LATE 3 | EARLY 4 | RANK #215 | SPON 9
Volume-matched condition peers
Nearest open-share peer: Cutaneous Melanoma (52% recruiting · 31 trials)
Congenital Heart Disease lists 33 open slots (52% of 64 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Congenital Heart Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Congenital Heart Disease is recruiting above its size-band peers.
33 of 64 indexed trials (51.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Congenital Heart Disease trials is spread across many organizations.
Boston Children's Hospital accounts for 9 of 64 trials (14.1%). 42 distinct sponsors appear on at least one study for this condition label.
-
Typical Congenital Heart Disease enrolment sits around 92 participants.
Median target enrolment is 92 among the 64 trials that report a genuine target (sentinel values excluded). 33 of those (51.6%) plan for fewer than 100 participants.
-
Congenital Heart Disease splits between interventional and observational designs.
34 interventional and 30 observational studies make up this index (53.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
64 total, page 2 of 2
Improving Motor Skill Development in Infants After Cardiac Surgery
University of Michigan
NCT02700646
Splanchnic and Renal Tissue Oxygenation During Enteral Feedings in Neonates With Patent Ductus Arteriosus
University of Utah
NCT03551600
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
University of California, Los Angeles
NCT05049590
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
University of Colorado, Denver
NCT02728128
Dynamic Critical Congenital Heart Screening With Addition of Perfusion Measurements
University of California, Davis
NCT05637814
Does Modified Ultrafiltration Affect Thromboelastography Results?
Wake Forest University Health Sciences
NCT03214120
Determination of the Minimal Concentration of Antifibrinolytics Required to Inhibit t-PA-activated Fibrinolysis
Boston Children's Hospital
NCT02352675
Acetaminophen for Oxidative Stress After Cardiopulmonary Bypass
Vanderbilt University Medical Center
NCT01228305
Neurodevelopmental Outcomes in Hypoplastic Left Heart Syndrome
Emory University
NCT00399555
MyHeartBaby: An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program
Emory University
NCT02895334
Enhanced External Counterpulsation in Patients With Fontan Circulation
Boston Children's Hospital
NCT04956952
Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children
Vanderbilt University Medical Center
NCT00848250
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
Boston Children's Hospital
NCT01977222
Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells
Timothy J Nelson, MD, PhD
NCT02549625
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 1 |
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Congenital Heart Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Congenital Heart Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Congenital Heart Disease page
64 registered trials, 33 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 33 Congenital Heart Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Boston Children's Hospital sponsors the most Congenital Heart Disease trials on record, review their full trial history before evaluating a specific study. See Boston Children's Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Congenital Heart Disease condition card totals 64 registered trials; most-linked intervention Harmony TPV System; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.